Alle Insider-Transaktionen auf den wichtigsten Aktienmärkten
| 30 Tage | Letzte 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | -9% | 8.2% | 15.1% |
| Erfolgsquote | 0% | 68% | 82% |
| Transaktionen |
8
0% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Chairman of Research and Development, Director | BridgeBio Pharma Inc | 1. Januar 2019 - |
| Executive Vice President - Research, Chief Scientific Officer | Genentech Inc | 1. Januar 2008 - |
| Independent Director | Alector Inc | 1. Oktober 2018 - |
| Independent Director | Xenon Pharmaceuticals Inc | 16. März 2015 - 14. Januar 2020 |
| Director | BridgeBio Pharma Inc | 1. Januar 2018 - 1. Januar 2019 |
| Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development | Roche Holding AG | 1. Januar 2009 - 31. Dezember 2014 |